<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Aptos;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
font-size:11.0pt;
font-family:"Aptos",sans-serif;
mso-ligatures:standardcontextual;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#467886;
text-decoration:underline;}
span.EmailStyle22
{mso-style-type:personal-compose;
font-family:"Aptos",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;
mso-ligatures:none;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="en-NL" link="#467886" vlink="#96607D" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><span lang="en-NL" style="font-size:12.0pt">Dear all,<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="en-NL" style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="en-NL" style="font-size:12.0pt">Please see the message from Martijn van Houten (IXA-GO), concerning NIH applications, below (originally in Dutch, so I added a translation below).<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="en-NL"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="en-NL" style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US">Goedemorgen allen, <o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="NL">Er is weer nieuws vanuit de VS. Vanochtend hebben wij het bericht ontvangen (zie link:
</span><span lang="en-NL"><a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-104.html"><span lang="NL">https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-104.html</span></a></span><span lang="NL">) dat de NIH-subaward compliance procedures
worden herzien (ik denk dat we er rekening mee moeten houden dat de compliance aspecten flink zullen worden aangescherpt).
<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="NL"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span lang="NL" style="background:yellow;mso-highlight:yellow">Vooruitlopend op de nieuwe procedures (die worden verwacht in september 2025) is dat in de tussentijd geen nieuwe aanvragen, lopende aanvragen en/of verlengingen met internationale
NIH-subawards zullen worden goedgekeurd (ingangsdatum 1 mei 2025).</span></b><b><span lang="NL"><o:p></o:p></span></b></p>
<p><span lang="NL" style="font-size:11.0pt">Het</span><span lang="NL"> </span><span lang="NL" style="font-size:11.0pt">‘goede’ nieuws is dat niet alle subawards per direct worden stopgezet (projecten verlengd vóór 1 mei 2025 zullen gewoon doorgaan), maar nieuwe
aanvragen (of aanvragen die op dit moment nog in het proces zitten) zullen worden afgewezen en subawards die ná 1 mei 2025 verlengd moeten worden, zullen niet worden gehonoreerd (de genoemde drempelwaarde van $30.000 zullen wij vanwege de salariskosten snel
overschrijden).</span><span lang="NL"><o:p></o:p></span></p>
<p><span lang="NL" style="font-size:11.0pt">Dit nieuws is vanochtend pas bekend geworden. Uiteraard houden wij een vinger aan de pols en zullen wij jullie op de hoogte houden van eventuele nieuwe ontwikkelingen. Ik heb verschillende relevante functionarissen
bij BBO, BJZ en Project Control ook van dit nieuws op de hoogte gebracht. <o:p></o:p></span></p>
<p><span lang="NL" style="font-size:11.0pt">Mochten er nog vragen zijn naar aanleiding van de mail, dan hoor ik dat uiteraard graag. <o:p></o:p></span></p>
<p><span lang="NL"><o:p> </o:p></span></p>
<p><b><span lang="NL">English translation:</span></b><span lang="NL"><o:p></o:p></span></p>
<p><span lang="NL" style="font-size:11.0pt">Good morning all, <o:p></o:p></span></p>
<p><span lang="NL" style="font-size:11.0pt">There is news from the US again. </span>
<span lang="EN-US" style="font-size:11.0pt">This morning we received notification (see link:
</span><span lang="EN-US">: </span><span lang="en-NL"><a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-104.html"><span lang="EN-US">https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-104.html</span></a></span><span lang="NL" style="font-size:11.0pt"><a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-104.html"></a></span><span lang="EN-US" style="font-size:11.0pt">)
that the NIH subaward compliance procedures are being revised (I think we should expect that the compliance aspects will be tightened up considerably).
<o:p></o:p></span></p>
<p><b><span lang="EN-US" style="font-size:11.0pt;background:yellow;mso-highlight:yellow">Anticipating the new procedures (expected in September 2025) no new applications, pending applications and/or renewals with international NIH subawards will be approved
(effective date 1 May 2025).</span></b><b><span lang="EN-US" style="font-size:11.0pt"><o:p></o:p></span></b></p>
<p><span lang="NL" style="font-size:11.0pt">The “good” news is that not all subawards will be discontinued immediately (projects extended before 1 May 2025 will continue as usual), but new applications (or those currently still in the process) will be rejected
and subawards to be extended after 1 May 2025 will not be honoured (we will quickly exceed the aforementioned $30,000 threshold due to salary costs).<o:p></o:p></span></p>
<p><span lang="NL" style="font-size:11.0pt">This news came out only this morning. Naturally, we will keep a finger on the pulse and will keep you informed of any new developments. I have also informed various relevant officials at BBO, BJZ and Project Control
of this news. <o:p></o:p></span></p>
<p><span lang="NL" style="font-size:11.0pt">If there are any questions in response to the e-mail, I would of course be happy to hear from you.<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">Met vriendelijke groet/kind regards,
</span><span lang="NL" style="font-size:12.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"><o:p></o:p></span></p>
<p class="MsoNormal" style="margin-top:12.75pt"><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">Martijn van Houten<o:p></o:p></span></p>
<p class="MsoNormal"><b><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:#0077B3;mso-fareast-language:#2000">Grants Compliance Officer/LEAR/SO<o:p></o:p></span></b></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:#0077B3;mso-fareast-language:#2000">Insitutional Affairs, Grants Office (IXA-GO)<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:#0077B3;mso-fareast-language:#2000">PIC:<b> 954530344
</b>(Stichting VU)<b><o:p></o:p></b></span></p>
<p class="MsoNormal" style="margin-top:12.75pt"><span lang="NL" style="font-size:12.0pt;mso-ligatures:none;mso-fareast-language:#2000"><img border="0" width="239" height="71" style="width:2.493in;height:.743in" id="Afbeelding_x0020_2" src="cid:image001.png@01DBBB56.29B12B60"><img border="0" width="116" height="68" style="width:1.2083in;height:.7083in" id="Afbeelding_x0020_1" src="cid:image002.png@01DBBB56.29B12B60"></span><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"><o:p></o:p></span></p>
<p class="MsoNormal" style="margin-top:12.75pt"><b><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">Working days:
</span></b><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">Mo, Tu, Th, Fr |
<b>T </b>+31 (0)20 59 83375 | <b>M </b>+31 (0)6 421 98319 | </span><span lang="en-NL"><a href="mailto:e.m.j.van.houten@vu.nl" target="_blank"><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:#0077B3;mso-fareast-language:#2000">e.m.j.van.houten@vu.nl</span></a></span><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">Mailing address:
</span></b><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">De Boelelaan 1105, 1081 HV Amsterdam<o:p></o:p></span></p>
<p class="MsoNormal"><b><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">Visiting address
</span></b><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">Main Building, 1E Wing |
</span><span lang="en-NL"><a href="https://vu.nl/en/about-vu/more-about/about-the-vu-website" target="_blank"><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:#0077B3;mso-fareast-language:#2000">E-mail disclaimer</span></a></span><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000">
| </span><span lang="en-NL"><a href="https://vu.nl/en/" target="_blank"><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:#0077B3;mso-fareast-language:#2000">www.vu.nl</span></a></span><span lang="EN-US" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"><o:p></o:p></span></p>
<p class="MsoNormal" style="margin-top:12.75pt;mso-margin-bottom-alt:auto"><a href="https://www.facebook.com/vuamsterdam/" target="_blank"><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:blue;mso-ligatures:none;mso-fareast-language:#2000;text-decoration:none"><img border="0" width="20" height="20" style="width:.2083in;height:.2083in" id="Picture_x0020_9" src="cid:image003.png@01DBBB56.29B12B60" alt="logo"></span></a><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"> </span><a href="https://www.instagram.com/vuamsterdam/" target="_blank"><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:blue;mso-ligatures:none;mso-fareast-language:#2000;text-decoration:none"><img border="0" width="20" height="20" style="width:.2083in;height:.2083in" id="Picture_x0020_8" src="cid:image004.png@01DBBB56.29B12B60" alt="logo"></span></a><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"> </span><a href="https://www.linkedin.com/school/vrije-universiteit-amsterdam/" target="_blank"><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:blue;mso-ligatures:none;mso-fareast-language:#2000;text-decoration:none"><img border="0" width="20" height="20" style="width:.2083in;height:.2083in" id="Picture_x0020_7" src="cid:image005.png@01DBBB56.29B12B60" alt="logo"></span></a><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"> </span><a href="https://x.com/#!/vuamsterdam" target="_blank"><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:blue;mso-ligatures:none;mso-fareast-language:#2000;text-decoration:none"><img border="0" width="20" height="20" style="width:.2083in;height:.2083in" id="Picture_x0020_1" src="cid:image006.png@01DBBB56.29B12B60" alt="logo"></span></a><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"> </span><a href="https://www.youtube.com/user/vrijeuniversiteit" target="_blank"><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;color:blue;mso-ligatures:none;mso-fareast-language:#2000;text-decoration:none"><img border="0" width="20" height="20" style="width:.2083in;height:.2083in" id="Picture_x0020_5" src="cid:image007.png@01DBBB56.29B12B60" alt="logo"></span></a><span lang="NL" style="font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-language:#2000"><o:p></o:p></span></p>
</div>
</body>
</html>